Skip to main content
Log in

Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats

  • Published:
AAPS PharmSci Aims and scope Submit manuscript

Abstract

Literature reports have suggested that hemodynamic response toward organic nitrates may be reduced in obese patients, but this effect has not been studied. We compared the mean arterial pressure (MAP) responses toward single doses of nitroglycerin (NTG), 0.5–50μg) in conscious Zucker obese (ZOB), Zucker lean (ZL), and Sprague-Dawley (SD) rats. NTG tolerance development in these animal groups was separately examined. Rats received 1 and 10μg/min of NTG or vehicle infusion, and the maximal MAP response to an hourly 30μg NTG IVchallenge dose (CD) was measured. Steady-state NTG plasma concentrations were measured during 10μg/min NTG infusion. The Emax and ED50 values obtained were 33.9± 3.6 and 3.5±1.7μg for SD rats, 33.2±4.1 and 3.0±1.4μg for ZL rats, and 34.8±3.9 and 5.3±2.8μg for ZOB rats, respectively. No difference was found in the dose-response curves among these 3 groups (p>.05, 2-way ANOVA). Neither the dynamics of NTG tolerance development, nor the steady-state NTG plasma concentrations, were found to differ among these 3 animal groups. These results showed that ZOB rats are not more resistant to the hemodynamic effects of organic nitrates compared with their lean controls. Thus, the acute and chronic hemodynamic effects by the presence of obesity in a conscious animal model of genetic obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rippe JM, Crossley S, Ringer R. Obesity as a chronic disease modern medical and lifestyle management. J Am Diet Assoc 1998;98:S9–15.

    Article  Google Scholar 

  2. National Task Force on the Prevention and Treatment of Obesity Overweignt, obesity, and health risk. Arch Intern Med. 2000;160:898–904.

    Article  Google Scholar 

  3. Garrison RJ, Higgins MW, Kannel WB. Obesity and coronary heart disease. Curr Opin Lipidol. 1996;7:199–202.

    Article  CAS  PubMed  Google Scholar 

  4. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–643.

    CAS  PubMed  Google Scholar 

  5. Cheymol G. Drug pharmacokinetics in the obese. Fundam Clin Pharmacol. 1988;2:239–256.

    Article  CAS  PubMed  Google Scholar 

  6. Cheymol G. Effects of obesity on pharmacokinetics: implications for drug therapy. Clin Pharmacokinet. 2000;39:215–231.

    Article  CAS  PubMed  Google Scholar 

  7. Brouwer KL, Kostenbauder HB, McNamara PJ, Blouin RA. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration. J Pharmacol Exp Ther. 1984;231:649–653.

    CAS  PubMed  Google Scholar 

  8. Brouer KL, Kostenbauder HB, McNamara PJ, Blouin RA. Phernobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction. J Pharmacol Exp Ther. 1984;231:654–659.

    Google Scholar 

  9. Brunner LJ, Vadiei K, Luke DR. Cyclosporine disposition in the hyperlipidemic rat model. Res Commun Chem Pathol Pharmacol. 1988;59:339–348.

    CAS  PubMed  Google Scholar 

  10. Chaudhary IP, Tuntaterdtum S, McNamara PJ, Robertson LW, Blouin RA. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways. J Pharmacol Exp Ther. 1993;265:1333–1338.

    CAS  PubMed  Google Scholar 

  11. Todd EL, Abernethy DR. Pharmacokinetics and dynamics of (+/−)-verapamil in lean and obese Zucker rats. J Pharmacol Exp Ther. 1986;238:642–647.

    CAS  PubMed  Google Scholar 

  12. Mathe D. Dyslipidemia and diabetes: animal models Diabetes Metab. 1995;21:106–111.

    CAS  Google Scholar 

  13. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A. 1994;91:10878–10882.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH, Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats: role of serine palmitoyltransferase overexpression. J Biol Chem. 1998;273:32487–32490.

    Article  CAS  PubMed  Google Scholar 

  15. Laight DW, Desai KM, Anggard EE, Carrier MJ. Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo. Eur J Pharmacol. 2000;402:95–99.

    Article  CAS  PubMed  Google Scholar 

  16. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. Faseb J. 2001;15:312–321.

    Article  CAS  PubMed  Google Scholar 

  17. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:771–776.

    CAS  PubMed  Google Scholar 

  18. McVeigh G, Brennan G, Hayes R, Johnston D. Primary nitrate tolerance in diabetes mellitus. Diabetologia. 1994;37:115–117.

    Article  CAS  PubMed  Google Scholar 

  19. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest. 1995;95:187–194.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yap PS, Fung HL. Pharmacokinetics of nitroglycerin in rats. J Pharm Sci. 1978;67:584–586.

    Article  CAS  PubMed  Google Scholar 

  21. Bauer JA, Fung HL. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther. 1991;256:249–254.

    CAS  PubMed  Google Scholar 

  22. Booth BP, Jacob S, Bauer JA, Fung HL. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats. J Cardiovasc Pharmacol. 1996;28:432–438.

    Article  CAS  PubMed  Google Scholar 

  23. Wang EQ, Balthasar JP, Fung HL. Pharmacodynamic modeling of in vivo nitroglycerin (NTG) tolerance in conscious rats: effects of dose and dosage regimen [Abstract]. AAPSPharmSci 2001:3:68.

    Google Scholar 

  24. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655–660.

    Article  CAS  PubMed  Google Scholar 

  25. Morley JE, Mattammal MB. Nitric oxide synthase levels in obese Zucker rats. Neurosci Lett. 1996;209:137–139.

    Article  CAS  PubMed  Google Scholar 

  26. Arcaro G Zamboni M, Rossi L, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord. 1999;23:936–942.

    Article  CAS  PubMed  Google Scholar 

  27. Hashimoto M, Akishita M, Eto M, et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord. 1998;22:477–484.

    Article  CAS  PubMed  Google Scholar 

  28. Ouchi Y, Han SZ, Kim S, et al. Augmented contractile function and abnormal Ca2+ handling in the aorta of Zucker obese rats with insulin resistance. Diabetes. 1996;45(suppl 3):S55–58.

    Article  Google Scholar 

  29. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev. 1998;14:241–249.

    Article  CAS  PubMed  Google Scholar 

  30. Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab. 1999;84:3212–3216.

    CAS  PubMed  Google Scholar 

  31. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567–574.

    Article  CAS  PubMed  Google Scholar 

  33. Laight DW, Kengatharan KM, Gopaul NK, Anggard EE, Carrier MJ. Investigation of oxidant stress and vasodepression to glyceryl trinitrate in the obese Zucker rat in vivo. Br J Pharmacol. 1998;125:895–901

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Perticone F, Ceravolo R, Candigliota M, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes. 2001;50:159–165.

    Article  CAS  PubMed  Google Scholar 

  35. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601–2610.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Bohlen HG, Lash JM. Endothelial-dependent vasodilation is preserved in non-insulin- dependent Zucker fatty diabetic rats. Am J Physiol. 1995;268:H2366–2374.

    CAS  PubMed  Google Scholar 

  37. Avogaro A, Piarulli F, Valerio A, et al. Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes. 1997;46:1040–1046.

    Article  CAS  PubMed  Google Scholar 

  38. Di Carli MF, Bianco-Batlles D, Landa ME, et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation. 1999;100:813–819.

    Article  PubMed  Google Scholar 

  39. Vincent HK, Powers SK, Stewart DJ, Shanely RA, Demirel H, Naito H. Obesity is associated with increased myocardial oxidative stress. Int J Obes Relat Metab Disord. 1999;23:67–74.

    Article  CAS  PubMed  Google Scholar 

  40. Laight DW, Desai KM, Gopaul NK, Anggard EE, Carrier MJ. F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Eur J Pharmacol. 1999;377:89–92.

    Article  CAS  PubMed  Google Scholar 

  41. Giugliano D, Marfella R, Verrazzo G, et al. Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants. Ann Intern Med. 1995;123:338–343.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ellen Q. Wang.

Additional information

Published: October 7, 2002

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, E.Q., Fung, HL. Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats. AAPS J 4, 28 (2002). https://doi.org/10.1208/ps040428

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/ps040428

Key words

Navigation